RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.

Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.

Add to Collection
2017 Nov Others Fist_Author_Year_PM

Full Author : ['Dash, Ranjeet Prasad', 'Babu, R Jayachandra', 'Srinivas, Nuggehally R']
Journal Title : Xenobiotica; the fate of foreign compounds in biological systems
Chapter : Section3
Journal Year : 2017
Cited by : Not Available

1. Several sodium-glucose cotransporter-2 (SGLT-2) inhibitors are in clinical use for the management of type 2 diabetes. The objectives of the current review were: (a) to provide a comparative pharmacokinetics including absorption, distribution, metabolis.....

Keywords : ["three inhibitor sergliflozin remogliflozin", "comparative pharmacokinetic", "overview", "ertugliflozin"]